Literature DB >> 1053697

Inhibition by 4'-demethyl-epipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) of human lymphoblast cultures in G2 phase of the cell cycle.

N C Misra, D W Roberts.   

Abstract

4'-Demethyl-epipodophyllotoxin 9-(4,6-0-2-thenylidene-beta-D-glucopyranoside) is a semisynthetic derivative of podophyllotoxin with oncolytic activity against a variety of neoplasms, Unlike the parent compound and other derivatives, which cause methaphase arrest, 4'-Demethyl-epipodophyllotoxin 9-(4,6-0-2-thenylidene-beta-D-glucopyranoside) apparently blocks the entry of CCRF-CEM cells into mitosis by inhibiting cells in the G2 phase of the cell cycle. The inhibition of precursor incorporation into DNA, RNA, and the protein, if observed, was delayed and probably secondary to inhibition of cells in the G2 phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1053697

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Topoisomerase-specific drug sensitivity in relation to cell cycle progression.

Authors:  K C Chow; W E Ross
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

2.  Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.

Authors:  D Roberts; T Lee; E Parganas; L Wiggins; J Yalowich; R Ashmun
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 3.  The molecular basis of drug-induced G2 arrest in mammalian cells.

Authors:  P N Rao
Journal:  Mol Cell Biochem       Date:  1980-01-16       Impact factor: 3.396

4.  Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.

Authors:  D W Roberts; P D Foglesong; E Parganas; L Wiggins
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.

Authors:  C Collins; C S Higano; R B Livingston; B R Griffin; M D Keppen; T P Miller
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells.

Authors:  P R Andreassen; R L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 7.  Podophyllotoxin derivative VP 16-213.

Authors:  A M Arnold
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis.

Authors:  M J Meddens; J Thompson; W C Bauer; J Hermans; R van Furth
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 9.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

10.  Impaired germ cell development due to compromised cell cycle progression in Skp2-deficient mice.

Authors:  Abbas Fotovati; Keiko Nakayama; Keiichi I Nakayama
Journal:  Cell Div       Date:  2006-04-07       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.